Vanberra Signal

FidoCure

Curated by Signal

Digital platform transforming canine cancer care through AI-driven precision medicine

Overview

Digital platform transforming canine cancer care through AI-driven precision medicine. It provides genomics database which uses genomic testing to offer veterinarians with data, enabling to tailor cancer therapies for individual dog patient. It also provides veterinary services such as medications, therapies, and more for pets. It harness data from naturally occurring canine cancers via next-generation sequencing and clinical information. It proprietary learning database for canine cancer. It offers is pioneering first-in-class care for canine cancer, It represents the need for pet dogs. by connecting human and veterinary oncology.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online marketplace that sells hemp-based cannabis products

    Health TechnologyCasper, United States
  • Provider of indoor growing systems for cannabis plants

    Health TechnologyUnited States
  • Provider of SaaS-based laboratory information management system

    Health TechnologySan Francisco, United States

About FidoCure

What does FidoCure do?

Digital platform transforming canine cancer care through AI-driven precision medicine.

Where is FidoCure headquartered?

FidoCure is headquartered in Palo Alto, United States.

When was FidoCure founded?

FidoCure was founded in 2016.

Which sector is FidoCure in?

FidoCure operates in Health Technology.

Who are FidoCure's competitors?

Companies similar to FidoCure include CakeRX, Grow Enclosures, and Luminate Health.